MedPath
FDA Approval

Oxybutynin Chloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Novitium Pharma LLC
DUNS: 080301870
Effective Date
August 23, 2021
Labeling Type
Human Prescription Drug Label
Oxybutynin(5 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Novitium Pharma LLC

Novitium Pharma LLC

080301870

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxybutynin Chloride

Product Details

NDC Product Code
70954-005
Application Number
ANDA209823
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 24, 2021
Code: L9F3D9RENQClass: ACTIBQuantity: 5 mg in 1 1
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
© Copyright 2025. All Rights Reserved by MedPath